Home Infusion Therapy Market Worth $61.7 Billion By 2030

Published On: November 23, 2022

The global home infusion therapy market reached a valuation of USD 31.0 billion in 2021 and is anticipated to total USD 61.7 billion by 2030. The market is expected to expand at a CAGR of 7.9% from 2022 to 2030. The growth of the market is attributed to the rising adoption of treatments at homes through catheters and needles. The favorable government policies and guidelines support market growth. The administration of drugs at home is convenient and affordable for the general population. Hence, more population are preferring home infusion therapies for treatment solutions, benefitting the market growth. 

The growing geriatric population and rising prevalence of chronic disease are leading to the emergence of different treatment options According to the WHO, chronic diseases accounted for 60% of total deaths in 2019 and the number increased in followed years This is creating the need for infusion of nutritional products and medications. This, in turn, is expected to boost the home infusion therapy demand during the forecast period. 

During the COVID-19 pandemic, the population was seeking treatment options to prevent infection of disease. Moreover, to fight against the disease, the immune system of the patients needed to boost. Hence, the administration of required nutrition was provided to the patients through home infusion therapies. The low-cost therapy and reduced operating hours led the pathway for the market to boost. In future years, home infusion therapy is estimated to support patients and make an impact on the healthcare system.

 To request a sample copy or view summary of this report, "please" click the link below:


Home Infusion Therapy Market Report Highlights

• Based on the product, the infusion pumps segment led the market accounting for over 50% of the total market share in 2021 The availability of the enteral, syringe, multichannel, and peristaltic pumps products are contributing to the segment growth

• Based on the application insights, the anti-infective segment accounted for over 25% of the total market revenue share in 2021. The growth of the segment is attributed to the rising prevalence of infectious disease. A significant number of procedures are being performed for the conduction of antifungal and antibiotic drug administration. The segment growth is due to the need for the reduction of other hospital-acquired infections (HAIs)

• Based on the regional insights, North America led the market in 2021, accounting for over 55% of the total market share. The growing research and development activities in the healthcare system are attributed to the market growth in the region. Moreover, the surge of new technologies in infusion pumps is creating opportunities for the market to expand significantly in the region during the forecast period

Home infusion Therapy Market Report Segments

Home infusion Therapy Product Outlook (Revenue, USD Million, 2017 - 2030)
    • Infusion Pumps
        • Elastomeric
        • Electromechanical
        • Gravity
        • Others
    • Intravenous Sets
    • IV Cannulas
    • Needleless Connectors

Home infusion Therapy Application Outlook (Revenue, USD Million, 2017 - 2030)
    • Anti-infective
    • Endocrinology
        • Diabetes
        • Others
    • Hydration Therapy
        • Athletes
        • Others
    • Chemotherapy
    • Enteral Nutrition
    • Parenteral Nutrition
    • Specialty Pharmaceuticals
    • Others

Home infusion Therapy Route of Administration Outlook (Revenue, USD Million, 2017 - 2030)
    • Intramuscular
    • Subcutaneously
    • Epidural

Home infusion Therapy Regional Outlook (Revenue, USD Million, 2017 - 2030)
    • North America
        • U.S.
        • Canada
    • Europe
        • U.K.
        • Germany
        • France
        • Spain
        • Italy
        • Netherlands
        • Belgium
        • Switzerland
        • Russia
        • Sweden
    • Asia Pacific
        • India
        • Japan
        • China
        • Australia
        • South Korea
        • Malaysia
        • Indonesia
        • Singapore
        • Philippines
        • Thailand
    • Latin America
        • Brazil
        • Mexico
        • Argentina
        • Colombia
        • Chile
    • Middle East & Africa
        • South Africa
        • Saudi Arabia
        • UAE
        • Israel
        • Egypt

List of key players of the global Home Infusion Therapy Market
    • CVS/Coram
    • Option Care Health
    • CareFusion Corporation
    • BriovaRx/Diplomat (UnitedHealth Optum)
    • PharMerica
    • Fresenius Kabi
    • ICU Medical, Inc.
    • B. Braun Melsungen AG
    • Baxter
    • BD
    • Caesarea Medical Electronics
    • Smiths Medical
    • Terumo Corporation
    • JMS Co. Ltd.